Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · March 18, 2023

Outcomes of Nintedanib in Children and Adolescents With Fibrosing Interstitial Lung Disease

The European Respiratory Journal


Additional Info

The European Respiratory Journal
Nintedanib in children and adolescents with fibrosing interstitial lung diseases
Eur. Respir. J. 2023 Feb 01;[EPub Ahead of Print], R Deterding, LR Young, EM DeBoer, D Warburton, S Cunningham, N Schwerk, KR Flaherty, KK Brown, M Dumistracel, E Erhardt, J Bertulis, M Gahlemann, S Stowasser, M Griese

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading